Last year was no small challenge for many investors, but the tides appear to have shifted for the better so far in 2023. Some companies have even performed well throughout all these ups and downs.

Consider biotech giants Vertex Pharmaceuticals (NASDAQ: VRTX) and Eli Lilly (NYSE: LLY). It is no wonder these corporations have been performing so well; both have excellent long-term prospects that make their shares worth buying this month (or almost any month) and holding onto for a long time.

Let's see why investors might consider both stocks for their portfolios now.

Continue reading

Source Fool.com